The transfer of ideas from laboratory to industry is to be accelerated by the implementation of the project of the National Centre for Biotechnology in Veterinary Medicine NaCeBiVet selected for funding within the second call of the National Centres of Competence announced by the Technology Agency of the Czech Republic.
https://www.tacr.cz/program-narodni-centra-kompetence-vyhlaseni-vysledku-2-verejne-souteze/
The implementation will start on 1 January 2023 and will be coordinated by the VRI. The implementation of the NaCeBiVet project is based on a long-term and systemic cooperation of 27 partners, 19 of whom are from the industry. One of the prerequisites is research capacity development towards transfer of research results, establishing effective cooperation with subjects from the industry and their preparedness for mutual cooperation, and transfer of the obtained results to industry, using effective technology tools.
The results that will be generated within the project, primarily in the field of biotechnology in diagnostics, prevention, therapy, nutrition and reproduction, will, thanks to their quality, innovative nature and potential, not only bring benefits to their end-users, but also contribute to the improvement in competitiveness of manufacturers and distributors.
We are pleased that the research plan is among the most highly rated ones by foreign and domestic evaluators, which can be considered a sign of high quality and potential. We will spare no effort in confirming and maintaining this precondition by the project implementation”, says Martin Faldyna, VRI Director and project investigator.
“By linking excellence in research with technological trends and new or highly innovative outcomes, the project is intended to offer the partner companies an opportunity for growth. Thanks the international collaboration, an increase in the companies’ opportunities to establish themselves on foreign markets is also expected”, adds Ildikó Csölle Putzová, on behalf of the project coordination team.
